WO2017216818A1 - Anaerobic growth of bacteria in unicellular alga - Google Patents
Anaerobic growth of bacteria in unicellular alga Download PDFInfo
- Publication number
- WO2017216818A1 WO2017216818A1 PCT/IT2016/000158 IT2016000158W WO2017216818A1 WO 2017216818 A1 WO2017216818 A1 WO 2017216818A1 IT 2016000158 W IT2016000158 W IT 2016000158W WO 2017216818 A1 WO2017216818 A1 WO 2017216818A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- culture
- extract
- anaerobic
- growth
- unicellular
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 41
- 230000009604 anaerobic growth Effects 0.000 title description 3
- 239000000284 extract Substances 0.000 claims abstract description 47
- 230000012010 growth Effects 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 32
- 241000186610 Lactobacillus sp. Species 0.000 claims abstract description 23
- 239000006041 probiotic Substances 0.000 claims abstract description 22
- 235000018291 probiotics Nutrition 0.000 claims abstract description 22
- 230000001580 bacterial effect Effects 0.000 claims abstract description 16
- 239000001963 growth medium Substances 0.000 claims abstract description 15
- 230000000529 probiotic effect Effects 0.000 claims abstract description 15
- 241001148471 unidentified anaerobic bacterium Species 0.000 claims abstract description 10
- 235000016709 nutrition Nutrition 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 6
- 239000002537 cosmetic Substances 0.000 claims abstract description 5
- 238000011081 inoculation Methods 0.000 claims abstract description 5
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 4
- 239000002609 medium Substances 0.000 claims abstract description 4
- 241000124105 Isochrysis sp. Species 0.000 claims description 23
- 241000195493 Cryptophyta Species 0.000 claims description 19
- 241001250129 Nannochloropsis gaditana Species 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- 235000000346 sugar Nutrition 0.000 claims description 15
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 11
- 150000008163 sugars Chemical class 0.000 claims description 7
- 150000002632 lipids Chemical class 0.000 claims description 6
- 230000009286 beneficial effect Effects 0.000 claims description 5
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 4
- 239000006014 omega-3 oil Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 235000006486 human diet Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 241000238582 Artemia Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000237519 Bivalvia Species 0.000 description 1
- 241000754798 Calophyllum brasiliense Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 241001501885 Isochrysis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000700141 Rotifera Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
Definitions
- the present invention relates to a novel method for microbiological culture. More particularly, the present invention relates to a method of culture of a probiotic anaerobic bacterium, both obligate and facultative in unicellular algae, with a high nutritional value for human supply, in particular rich in omega-3.
- probiotics based on different bacterial strains are available on the market (generally Lactobacilli or Bifidobacteria) .
- These probiotics produce lactic acid by fermentation of sugars, in different formulations and concentrations.
- the beneficial properties of lactic acid are widely recognized, some closely related with bowel health, through the edit action of the intestinal flora.
- fermented foods e.g. Yogurt, cheese
- nutritional qualities of different unicellular algae e.g. Spirulina, Chlorella, Dunaniella
- Spirulina e.g. Spirulina, Chlorella, Dunaniella
- These algae are rich in protein, minerals and trace elements and they are already greatly appreciated as supplements in the human diet.
- omega-3 polyunsaturated fatty acids
- the present invention aims to provide a product that combines the beneficial properties of probiotics and the ones of unicellular algae rich in omega-3 fatty acids. Specifically, the present invention arises the purpose of providing a product based on probiotic strains grown in unicellular algae rich in omega - 3 which combines the beneficial properties of the cultivated probiotics with the omega - 3 fatty acids .
- the present invention aims to provide a product suitable to constitute the source of probiotic bacteria grown under anaerobic conditions (fermentation) in a culture medium, based on unicellular algae rich in omega - 3, which is suitable for the growing of bacterial strains and, at the end of the bacterial culture, it must not be removed because it provides an important contribution to the human diet, as a source of omega - 3.
- this preparation has nutritional value (since the probiotic, during the fermentation time, consumes the glucose component of a unicellular alga, leaving unchanged the lipid portion rich in omega-3 available to the human consumption) and therapeutic (both the curative effects of the probiotic and the anti inflammatory and anti - oxidant of the omega - 3 are known) and cosmetic properties (different probiotic strains produce metabolites of glycerin and other moisturizing , ions and heavy metals, where ⁇ bacterial metabolite ' means any molecule of neo-synthesis that is metabolized by a bacterium, which is economically interesting and obtained by anaerobic growth) .
- an homogenized unicellular microalgae is accessible from a bacterium, which is able to grow inside it in anaerobic conditions.
- a method of culture of an anaerobic bacterium both obligate or facultative which is inoculated in a homogenised or entire extract of unicellular microalgae in a solvent under anaerobic conditions; the unicellular microalgae has a concentration in the solvent able to sustain the growth of the anaerobic bacteria.
- the present invention possibly involves the further addition of a complement of sugar to the extract of unicellular microalgae in the method of culture of the anaerobic bacteria.
- the method presented in this invention is economically advantageous and useful for the activation of the metabolism of the anaerobic bacterium and for its tropism in the intestinal lumen.
- the method makes superfluous each subsequent purification step of the bacterium from its growth medium, which in turn has an important nutritional value in the lipid content and therapeutic properties due to the presence of omega - 3.
- the approach of the present invention does not contain any extraction of the organic phase or enrichment of the lipid phase.
- the microalga is used in its entirety, since the component of sugar and protein is functional to the growth of the bacterium, while the lipid portion is maintained as a source of omega - 3 fatty acids in the final fermented product .
- the extract of single-cell microalgae is an extract of Nannochloropsis gaditana homogenized and, in particular, that the extract of Nannochloropsis gaditana has been obtained starting from a fresh culture of Nannochloropsis gaditana in the exponential phase of growth.
- the single- cell microalgae extract is an extract of Isochrysis sp. And, more particularly, that the extract of Isochrysis sp. has been obtained from Isochrysis sp. lyophilized.
- a product containing a fermented is so obtained, comprising in combination both a bacterial culture medium and a bacterial population grown in it, obtained by the method of culture of an anaerobic bacterium as described above, for which the product is suitable as source of probiotic and simultaneously as source of a fermented of the unicellular alga containing omega- 3 for nutritional, therapeutic or cosmetic use.
- Lactobacillus sp. is the inoculated anaerobic bacterium.
- a product containing an entire fermented is so obtained as described above, wherein the anaerobic bacterium is Lactobacillus sp., for which the product is suitable as a source of probiotic and, at the same time, as a dietary supplement of the fermented of algae, rich in omega - 3, used for the growth of the bacterium.
- the present invention defines a culture technique of obligate or facultative anaerobic bacteria, which does not resort to the microbiological culture media available on the market, and uses an entire or homogenate extract of single-cell microalgae in oxygen-free conditions as the sole source of proliferation of the bacteria.
- the fermented product obtained with the method of the present invention is completely free of animal elements, respect to probiotics grown in classical culture broths, containing extracts of lean meat, rich in amino acids, peptides, nucleotides, organic acids, vitamins and minerals. Therefore, a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 1 attached hereto, constitutes the object of the present invention.
- object of the present invention is also a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 2 attached hereto. Preferred examples of this method are recited in the dependent claims 3; 4; 5 ; 6, e 7. Object of the present invention is also a product containing an entire fermented, comprising in combination both a medium of bacterial culture and a bacterial population grown in it, as recited in the attached claim 8. A preferred example of this method is recited in the attached dependent claims 9.
- the present invention will be fully understood based on the following detailed description of the best way of implementing it, given only as example, absolutely not limitative of the invention itself, in reference to the attached drawings, in which:
- FIG 1 is a diagram which shows the curves of bacterial growth under anaerobic conditions in an extract of a first strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture media commercially available, and
- FIGURE 2 is a diagram showing the curves of bacterial growth under anaerobic conditions in an extract of a second strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture medium commercially available.
- the present invention is a method of culture of an anaerobic bacterium, obligate or facultative, that inoculates anaerobic bacteria in a homogenate or entire extract of the unicellular alga in a solvent under anaerobic conditions.
- concentration of the unicellular alga in the solvent has to be effective to sustain the growth of anaerobic bacteria.
- the extract of unicellular algae is an homogenized extract of Nannochloropsis gaditana and the anaerobic bacterium, from the strain Lactobacillus sp..
- Nannochloropsis gaditana is a spheroidal microalgae of diameter about 2 - 3 micrometers, devoid of motor structures. Its lipid content is about 30% of its dry weight. It accumulates large concentrations of various pigments, such as, for example, astaxanthin, canthaxanthin and zeaxanthin. Nannochloropsis gaditana is also a food product and, indeed, it is used to produce dietary- supplements. It is also served at the restaurant in Spain in El Puerto de Santa Maria in Cadiz, in the area where it was isolated for the first time and where it still grows wild.
- Nannochloropsis gaditana the bioavailable sugars were measured in the laboratory by the Inventors and result to be dependent on the lysis method of microalgae and constitute from 4 % to 8 % of microalgae dry mass, distributed as follows: from 40% to 50 % of glucose; from 18% to 23 % of galactose; from 13% to from 2% to 4 % of xylose ; from 3% to 5 % of ribose ; from 4 % to 8 % other sugars .
- the extract Nannochloropsis gaditana may have been obtained from a fresh culture of Nannochloropsis gaditana in exponential phase of growth, and the micro-algae of the strain of Nannochloropsis gaditana was subjected to a mechanical homogenization process via a probe homogenizer with teflon head, by homogenization of 2 minutes at 14,000 rounds per minute.
- the parameter for the choice of the concentration of microalgae in physiological saline solution was determined based on obtaining an amount of sugar comparable with that described in the literature as sufficient to maintain fermentative metabolism of Lactobacillus sp., that is 10 grams per liter. In order to not compromise the isotonicity of the culture medium, the amount of 100 grams of dry mass per liter of physiological solution it was never exceeded.
- the concentration of extract of Nannochloropsis gaditana was less than 10 grams per litre. With this dilution the Inventors verified the growth with the extract of algae, but also with an addition of a complement of 5 grams of glucose per liter and with a culture medium MRS DE MAN - ROGOSA - SHARPE for lactobacilli , commercially available. In the exposed experiment a sterility control of the culture medium and of the extract of microalgae was included. Under the experimental conditions of Example I, the growth took place into sealed tubes, in fact, any induced correction of the acidity produced by lactic acid fermentation was not expected, it was therefore expected that the fermentation was stopped because of the acidification of the culture medium and because of sugar depletion.
- FIGURE 1 The results of the growth of Lactobacillus sp. in the extract of Nannochloropsis gaditana, fresh and homogenized, are illustrated in FIGURE 1, in which: the curve 1 is the growth curve obtained with the commercially available MRS culture medium; the curve 2 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) ; curve 3 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) with the addition of 5 grams of glucose per liter of physiological solution.
- the inventors revealed that, in the aforementioned experimental conditions, the suitably homogenized extract of Nannochloropsis gaditana was able to support the growth of Lactobacillus sp. without the aid of any sugar integration, even if an addition of sugar sensibly improves the yield, at least for three days starting from the inoculation of the bacterium.
- the extract of unicellular microalgae is an extract of Isochrysis sp. and the strain of the anaerobic bacterium is Lactobacillus sp..
- Isochrysis sp. is a brown and flagellated unicellular alga, about 5 micrometers long and widely used in aquaculture. It has a high content of docosahexaenoic acid or DHA (omega - 3 fatty acid is the most effectively under the curative profile) and Isochrysis sp. is often used to enrich zooplankton (rotifers or Artemia) .
- Isochrysis sp. The high content of omega3 and sugar (about 30% of the dry weight) of Isochrysis sp., in addition to the absence of a cellulose capsule, makes Isochrysis sp. particularly suitable for the purposes of the present invention.
- the advantage of Isochrysis sp. is to have a high content of sugars and not to possess a cellulose capsule. This latter feature ensures that it is accessible to a bacterium and that is able to ensure the growth also in a non-homogenized state.
- Example II the extract of Isochrysis sp. was obtained from Isochrysis sp. lyophilized. Even under the experimental conditions of Example II the growth took place in sealed tubes in such a way that the application of any induced correction of acidity produced by lactic acid fermentation was not expected. It was therefore expected that the fermentation was stopped by the acidification of the culture medium and cause of sugar depletion.
- FIGURE 2 The results of the growth of Lactobacillus sp. in Isochrysis sp . extract are illustrated in FIGURE 2, in which: the curve 11 is the growth curve obtained with the commercially available MRS culture medium; the curve 12 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp.; the curve 13 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., with the addition of 5 grams of glucose per litre of physiological solution; the curve 14 is the growth curve of Lactobacillus sp. in the homogenized extract of Isochrysis sp.; the curve 15 is the growth curve of Lactobacillus sp.
- the curve 16 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp. sterilized in an autoclave
- the curve 17 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution
- the curve 18 is the growth curve of Lactobacillus sp.
- the curve 19 is the growth curve of Lactobacillus sp. in the extract of Isochrysis sp., homogenized and sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Method of culture of an anaerobic bacterium, obligate or facultative, in particular Lactobacillus sp., which comprises the inoculation of the anaerobic bacteria in an extract, homogenized or entire, of the unicellular microalgae in a solvent medium under anaerobic conditions. The unicellular microalgae have a concentration in the solvent medium able to sustain the growth of the anaerobic bacteria. With this method, a fermented comprising both a bacterial culture medium and a bacterial population grown in it is obtainable. The fermented is suitable to be inserted into the composition of a constituent source of a bacterium, in particular a probiotic, and, at the same time, of a fermented, in particular rich in omega - 3, for the growth of it, for nutritional, therapeutic and cosmetic use; in particular it can be used as a food supplement.
Description
ANAEROBIC GROWTH OF BACTERIA IN UNICELLULAR ALGA The present invention relates to a novel method for microbiological culture. More particularly, the present invention relates to a method of culture of a probiotic anaerobic bacterium, both obligate and facultative in unicellular algae, with a high nutritional value for human supply, in particular rich in omega-3. Nowadays probiotics based on different bacterial strains are available on the market (generally Lactobacilli or Bifidobacteria) . These probiotics produce lactic acid by fermentation of sugars, in different formulations and concentrations. The beneficial properties of lactic acid are widely recognized, some closely related with bowel health, through the edit action of the intestinal flora.
The positive effects of fermented foods (e.g. Yogurt, cheese) on the human organism have been known for a long time. Moreover, the nutritional qualities of different unicellular algae are also known (eg. Spirulina, Chlorella, Dunaniella) . These algae are rich in protein, minerals and trace elements and they are already greatly appreciated as supplements in the human diet.
Some of these algae are particularly rich in polyunsaturated fatty acids called omega-3, which make them particularly interesting, as the
00158 beneficial and curative properties of omega-3 are scientifically proven.
However, despite the known health benefits of probiotics and omega-3, nowadays, a product containing probiotic bacteria grown in unicellular algae rich in omega-3 doesn't exist on the market.
The present invention aims to provide a product that combines the beneficial properties of probiotics and the ones of unicellular algae rich in omega-3 fatty acids. Specifically, the present invention arises the purpose of providing a product based on probiotic strains grown in unicellular algae rich in omega - 3 which combines the beneficial properties of the cultivated probiotics with the omega - 3 fatty acids .
More in general, the present invention aims to provide a product suitable to constitute the source of probiotic bacteria grown under anaerobic conditions (fermentation) in a culture medium, based on unicellular algae rich in omega - 3, which is suitable for the growing of bacterial strains and, at the end of the bacterial culture, it must not be removed because it provides an important contribution to the human diet, as a source of omega - 3.
It should be emphasized that this preparation has nutritional value (since the probiotic, during the fermentation time, consumes the glucose component
of a unicellular alga, leaving unchanged the lipid portion rich in omega-3 available to the human consumption) and therapeutic (both the curative effects of the probiotic and the anti inflammatory and anti - oxidant of the omega - 3 are known) and cosmetic properties (different probiotic strains produce metabolites of glycerin and other moisturizing , ions and heavy metals, where Λ bacterial metabolite ' means any molecule of neo-synthesis that is metabolized by a bacterium, which is economically interesting and obtained by anaerobic growth) .
The Inventors have found that an homogenized unicellular microalgae, either encapsulated or free of the capsule, is accessible from a bacterium, which is able to grow inside it in anaerobic conditions. Thus, the aforementioned objectives are achieved with a method of culture of an anaerobic bacterium both obligate or facultative, which is inoculated in a homogenised or entire extract of unicellular microalgae in a solvent under anaerobic conditions; the unicellular microalgae has a concentration in the solvent able to sustain the growth of the anaerobic bacteria. The present invention possibly involves the further addition of a complement of sugar to the extract of unicellular microalgae in the method of culture of the anaerobic bacteria. The method presented in this
invention is economically advantageous and useful for the activation of the metabolism of the anaerobic bacterium and for its tropism in the intestinal lumen.
Moreover, the method makes superfluous each subsequent purification step of the bacterium from its growth medium, which in turn has an important nutritional value in the lipid content and therapeutic properties due to the presence of omega - 3.
Differently to what has been done so far in the use of unicellular algae with industrial purposes, for example as biofuels, or cosmetic, the approach of the present invention does not contain any extraction of the organic phase or enrichment of the lipid phase. The microalga is used in its entirety, since the component of sugar and protein is functional to the growth of the bacterium, while the lipid portion is maintained as a source of omega - 3 fatty acids in the final fermented product .
As explained above, in the present invention it is contemplated that, for the method of culture of an anaerobic probiotic bacterium, the extract of single-cell microalgae is an extract of Nannochloropsis gaditana homogenized and, in particular, that the extract of Nannochloropsis gaditana has been obtained starting from a fresh
culture of Nannochloropsis gaditana in the exponential phase of growth.
It is also contemplated that in the method of culture of an anaerobic bacterium according to the present invention, as described above, the single- cell microalgae extract is an extract of Isochrysis sp. And, more particularly, that the extract of Isochrysis sp. has been obtained from Isochrysis sp. lyophilized. A product containing a fermented is so obtained, comprising in combination both a bacterial culture medium and a bacterial population grown in it, obtained by the method of culture of an anaerobic bacterium as described above, for which the product is suitable as source of probiotic and simultaneously as source of a fermented of the unicellular alga containing omega- 3 for nutritional, therapeutic or cosmetic use.
Moreover, in the present invention it is contemplated that, in the method of culture of an anaerobic bacterium, as described above, Lactobacillus sp. is the inoculated anaerobic bacterium. A product containing an entire fermented is so obtained as described above, wherein the anaerobic bacterium is Lactobacillus sp., for which the product is suitable as a source of probiotic and, at the same time, as a dietary supplement of the fermented of algae, rich in omega - 3, used for the growth of the bacterium.
Thus, the present invention defines a culture technique of obligate or facultative anaerobic bacteria, which does not resort to the microbiological culture media available on the market, and uses an entire or homogenate extract of single-cell microalgae in oxygen-free conditions as the sole source of proliferation of the bacteria.
The fermented product obtained with the method of the present invention is completely free of animal elements, respect to probiotics grown in classical culture broths, containing extracts of lean meat, rich in amino acids, peptides, nucleotides, organic acids, vitamins and minerals. Therefore, a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 1 attached hereto, constitutes the object of the present invention.
In addition, object of the present invention is also a method of culture of an anaerobic bacterium, obligate or facultative, as recited in Claim 2 attached hereto. Preferred examples of this method are recited in the dependent claims 3; 4; 5 ; 6, e 7. Object of the present invention is also a product containing an entire fermented, comprising in combination both a medium of bacterial culture and a bacterial population grown in it, as recited in the attached claim 8.
A preferred example of this method is recited in the attached dependent claims 9. The present invention will be fully understood based on the following detailed description of the best way of implementing it, given only as example, absolutely not limitative of the invention itself, in reference to the attached drawings, in which:
- FIG 1 is a diagram which shows the curves of bacterial growth under anaerobic conditions in an extract of a first strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture media commercially available, and
- FIGURE 2 is a diagram showing the curves of bacterial growth under anaerobic conditions in an extract of a second strain of the unicellular alga in a bacterial culture according to the method of the present invention and in a culture medium commercially available.
The present invention is a method of culture of an anaerobic bacterium, obligate or facultative, that inoculates anaerobic bacteria in a homogenate or entire extract of the unicellular alga in a solvent under anaerobic conditions. The concentration of the unicellular alga in the
solvent has to be effective to sustain the growth of anaerobic bacteria.
It is contemplated to add a complement of sugars to the extract of single-celled algae.
EXAMPLE I
In this Example I, the extract of unicellular algae is an homogenized extract of Nannochloropsis gaditana and the anaerobic bacterium, from the strain Lactobacillus sp..
Nannochloropsis gaditana is a spheroidal microalgae of diameter about 2 - 3 micrometers, devoid of motor structures. Its lipid content is about 30% of its dry weight. It accumulates large concentrations of various pigments, such as, for example, astaxanthin, canthaxanthin and zeaxanthin. Nannochloropsis gaditana is also a food product and, indeed, it is used to produce dietary- supplements. It is also served at the restaurant in Spain in El Puerto de Santa Maria in Cadiz, in the area where it was isolated for the first time and where it still grows wild. For Nannochloropsis gaditana the bioavailable sugars were measured in the laboratory by the Inventors and result to be dependent on the lysis method of microalgae and constitute from 4 % to 8 % of microalgae dry mass, distributed as follows: from 40% to 50 % of glucose; from 18% to 23 % of galactose; from 13% to
from 2% to 4 % of xylose ; from 3% to 5 % of ribose ; from 4 % to 8 % other sugars .
In the present example the extract Nannochloropsis gaditana may have been obtained from a fresh culture of Nannochloropsis gaditana in exponential phase of growth, and the micro-algae of the strain of Nannochloropsis gaditana was subjected to a mechanical homogenization process via a probe homogenizer with teflon head, by homogenization of 2 minutes at 14,000 rounds per minute. Since the purpose of the extract of mxcroalga was to sustain the growth of the bacteria in the anaerobic fermentation conditions, the parameter for the choice of the concentration of microalgae in physiological saline solution was determined based on obtaining an amount of sugar comparable with that described in the literature as sufficient to maintain fermentative metabolism of Lactobacillus sp., that is 10 grams per liter. In order to not compromise the isotonicity of the culture medium, the amount of 100 grams of dry mass per liter of physiological solution it was never exceeded.
The concentration of extract of Nannochloropsis gaditana was less than 10 grams per litre. With this dilution the Inventors verified the growth with the extract of algae, but also with an addition of a complement of 5 grams of glucose
per liter and with a culture medium MRS DE MAN - ROGOSA - SHARPE for lactobacilli , commercially available. In the exposed experiment a sterility control of the culture medium and of the extract of microalgae was included. Under the experimental conditions of Example I, the growth took place into sealed tubes, in fact, any induced correction of the acidity produced by lactic acid fermentation was not expected, it was therefore expected that the fermentation was stopped because of the acidification of the culture medium and because of sugar depletion.
The results of the growth of Lactobacillus sp. in the extract of Nannochloropsis gaditana, fresh and homogenized, are illustrated in FIGURE 1, in which: the curve 1 is the growth curve obtained with the commercially available MRS culture medium; the curve 2 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) ; curve 3 is the growth curve of Lactobacillus sp. in the extract of Nannochloropsis gaditana (homogenized) with the addition of 5 grams of glucose per liter of physiological solution. Surprisingly the inventors revealed that, in the aforementioned experimental conditions, the suitably homogenized extract of Nannochloropsis gaditana was able to support the growth of Lactobacillus sp. without the aid of any sugar
integration, even if an addition of sugar sensibly improves the yield, at least for three days starting from the inoculation of the bacterium.
EXAMPLE II
In the Example II the extract of unicellular microalgae is an extract of Isochrysis sp. and the strain of the anaerobic bacterium is Lactobacillus sp.. Isochrysis sp. is a brown and flagellated unicellular alga, about 5 micrometers long and widely used in aquaculture. It has a high content of docosahexaenoic acid or DHA (omega - 3 fatty acid is the most effectively under the curative profile) and Isochrysis sp. is often used to enrich zooplankton (rotifers or Artemia) . It is considered a primary algae and it is the most commonly used to raise oysters, clams, mussels, scallops and in the shellfish farms. The high content of omega3 and sugar (about 30% of the dry weight) of Isochrysis sp., in addition to the absence of a cellulose capsule, makes Isochrysis sp. particularly suitable for the purposes of the present invention. The advantage of Isochrysis sp. is to have a high content of sugars and not to possess a cellulose capsule. This latter feature ensures that it is accessible to a bacterium and that is able to ensure the growth also in a non-homogenized state. On the contrary an encapsulated microalga is of difficult access for a bacterium and therefore the
culture is not possible without prior homogenization. In this Example II the extract of Isochrysis sp. was obtained from Isochrysis sp. lyophilized. Even under the experimental conditions of Example II the growth took place in sealed tubes in such a way that the application of any induced correction of acidity produced by lactic acid fermentation was not expected. It was therefore expected that the fermentation was stopped by the acidification of the culture medium and cause of sugar depletion.
The results of the growth of Lactobacillus sp. in Isochrysis sp . extract are illustrated in FIGURE 2, in which: the curve 11 is the growth curve obtained with the commercially available MRS culture medium; the curve 12 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp.; the curve 13 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., with the addition of 5 grams of glucose per litre of physiological solution; the curve 14 is the growth curve of Lactobacillus sp. in the homogenized extract of Isochrysis sp.; the curve 15 is the growth curve of Lactobacillus sp. in the homogenized extract of Isochrysis sp. with the addition of 5 grams of glucose per litre of physiological solution; the curve 16 is the growth curve of Lactobacillus sp. in the entire extract of
Isochrysis sp. sterilized in an autoclave; the curve 17 is the growth curve of Lactobacillus sp. in the entire extract of Isochrysis sp., sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution ; the curve 18 is the growth curve of Lactobacillus sp. in the extract of Isochrysis s ., homogenized and sterilized in an autoclave, and the curve 19 is the growth curve of Lactobacillus sp. in the extract of Isochrysis sp., homogenized and sterilized in an autoclave with the addition of 5 grams of glucose per litre of physiological solution.
The speed of growth of Lactobacillus sp. in the extract of Isochrysis sp. was higher from the first day of inoculation of the bacterium and it wasn't noticeable any advantage with the addition of 5 grams per liter of glucose. The bioavailable sugars were sufficient to ensure the growth of Lactobacillus sp. until at least 4 days after inoculation of this . The present invention has been shown in reference to specific examples thereof, but it must be expressly understood that variations may be made thereto without departing from the scope of the appended claims .
Claims
CLAIMS :
Method of culture of anaerobic bacteria, obligate or facultative, that provides the inoculation of the anaerobic bacteria in an extract, homogenate or entire, of unicellular algae rich in omega - 3 in a solvent under anaerobic conditions. Unicellular microalgae must have a concentration in the solvent, suitable to support the growth of the anaerobic bacteria .
Method of culture of an anaerobic bacterium as claimed in claim 1, further comprising the addition of a complement of sugars to the aforementioned extract of unicellular microalga.
Method of culture as claimed in claim 1 or 2, which also makes unnecessary any subsequent purification step of the bacteria from the growth medium, which in turn has an important nutritional value in lipid content and therapeutic properties due to the presence of omega - 3.
Method of culture of an anaerobic bacterium as claimed in any Claims from 1 to 3 , wherein the mentioned extract is an extract of homogenized unicellular microalgae Nannochloropsis gaditana .
Method of culture of an anaerobic bacterium as claimed in claim 4, wherein the mentioned extract of Nannochloropsis gaditana was obtained from a fresh culture of Nannochloropsis gaditana in exponential phase of growth .
Method of culture of an anaerobic bacterium as claimed in claim 1, wherein the mentioned unicellular algae extract is an extract of Isochrysis sp .
Method of culture of an anaerobic bacterium as claimed in claim 6, wherein the mentioned extract of Isochrysis sp . was obtained from Isochrysis sp . lyophilized.
Method of culture of an anaerobic bacterium as claimed in any Claims from 1 to 7 , wherein the mentioned anaerobic bacterium is Lactobacillus sp..
A product containing an entire fermented, comprising in combination both a medium of bacterial culture and a bacterial population grew in it. This is obtained by the method of culture of an anaerobic bacterium, obligate or facultative, as claimed in any Claims from 1 to 7, for which the product is suitable as a source of probiotic and at the same time of the fermented of algae for the growth of these, for nutritional, therapeutic or cosmetic use.
10. Product containing an entire fermented as claimed in claim 9, wherein the mentioned anaerobic bacterium is Lactobacillus sp.. The product is suitable as a source of probiotic and at the same time of the fermented of algae for the growth of the probiotic. This product can be used as a food supplement .
11. Product based on probiotic strains grown in unicellular algae rich in omega - 3 as claimed in any Claims from 1 to 7 which then combine the beneficial properties of the probiotics cultivated and omega - 3 fatty- acids .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2016/000158 WO2017216818A1 (en) | 2016-06-17 | 2016-06-17 | Anaerobic growth of bacteria in unicellular alga |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2016/000158 WO2017216818A1 (en) | 2016-06-17 | 2016-06-17 | Anaerobic growth of bacteria in unicellular alga |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017216818A1 true WO2017216818A1 (en) | 2017-12-21 |
Family
ID=56855772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IT2016/000158 WO2017216818A1 (en) | 2016-06-17 | 2016-06-17 | Anaerobic growth of bacteria in unicellular alga |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017216818A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800005108A1 (en) * | 2018-05-07 | 2019-11-07 | PROCEDURE FOR THE SYNTHESIS OF SILVER NANOPARTICLES BY MEANS OF PROBIOTIC STRAINS GROWN IN ALGAE, NANOPARTICLES SO OBTAINED AND RELATED USES |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006112364A1 (en) * | 2005-04-15 | 2006-10-26 | Dainippon Ink And Chemicals, Inc. | Hypotensive agent produced by cultivation of lactic acid bacterium |
US20140127761A1 (en) * | 2011-07-14 | 2014-05-08 | Ajinomoto Co., Inc. | Method for Producing Fatty Acid |
-
2016
- 2016-06-17 WO PCT/IT2016/000158 patent/WO2017216818A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006112364A1 (en) * | 2005-04-15 | 2006-10-26 | Dainippon Ink And Chemicals, Inc. | Hypotensive agent produced by cultivation of lactic acid bacterium |
US20140127761A1 (en) * | 2011-07-14 | 2014-05-08 | Ajinomoto Co., Inc. | Method for Producing Fatty Acid |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Week 200706, 2007 Derwent World Patents Index; AN 2007-056263, XP002767591 * |
MD. MAHABUBUR RAHMAN TALUKDER ET AL: "Microalgae (Nannochloropsis salina) biomass to lactic acid and lipid", BIOCHEMICAL ENGINEERING JOURNAL, vol. 68, 1 October 2012 (2012-10-01), pages 109 - 113, XP055140782, ISSN: 1369-703X, DOI: 10.1016/j.bej.2012.07.001 * |
RYCKEBOSCH ELINE ET AL: "Nutritional evaluation of microalgae oils rich in omega-3 long chain polyunsaturated fatty acids as an alternative for fish oil", FOOD CHEMISTRY, vol. 160, 2014, pages 393 - 400, XP028660381, ISSN: 0308-8146, DOI: 10.1016/J.FOODCHEM.2014.03.087 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800005108A1 (en) * | 2018-05-07 | 2019-11-07 | PROCEDURE FOR THE SYNTHESIS OF SILVER NANOPARTICLES BY MEANS OF PROBIOTIC STRAINS GROWN IN ALGAE, NANOPARTICLES SO OBTAINED AND RELATED USES | |
EP3567114A1 (en) * | 2018-05-07 | 2019-11-13 | OCEAN FARMA S.r.l | Process for the synthesis of silver nanoparticles using probiotic strains grown in algae, ternary mixture thus obtained and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Beheshtipour et al. | Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks | |
Iwamoto | Industrial production of microalgal cell‐mass and secondary products‐major industrial species: chlorella | |
CN103109930B (en) | Fruity probiotic yogurt slice containing antifreeze sericin peptide and method for preparing same | |
CN106399163B (en) | A kind of anti-aging probiotics preparation and preparation method | |
CN102271535B (en) | Sialic acid producing bacteria | |
JP2008136493A (en) | Method for production of arachidonic acid | |
CA2675691A1 (en) | Methods for producing polyunsaturated fatty acid and lipid containing polyunsaturated fatty acid | |
KR101921475B1 (en) | Method for manufacturing functional fermented material of Spirulia by lactic acid fermentation or yeast fermentation | |
AU2021202832B2 (en) | Repeated fed-batch culture methods | |
WO2015063282A1 (en) | Use of algae to increase the viable active biomass of lactic acid bacteria | |
KR102236782B1 (en) | Methods of oil production in microorganisms | |
WO2017216818A1 (en) | Anaerobic growth of bacteria in unicellular alga | |
JP6330237B2 (en) | Lactobacillus lactic acid bacteria culture-grade culture medium, Lactobacillus lactic acid bacteria culture method, and Lactobacillus lactic acid bacteria culture production method | |
JP6429162B1 (en) | Labyrinthula culture method | |
CN106399407B (en) | Utilize the method for acer truncatum buge oil Efficient Conversion preparation conjugated linoleic acid | |
AU2005302793A1 (en) | Process for preparing a bacterial culture, and the product prepared by the process | |
WO2023140321A1 (en) | Novel organism breeding technique | |
US20230235371A1 (en) | Method for culturing microorganisms for lipid accumulation | |
RU2541778C2 (en) | Method for production of bacterial concentrate and its application as probiotic biologically active food additive | |
AMIRKHANOVA et al. | BULLETIN OF THE KARAGANDA UNIVERSITY. BIOLOGY. MEDICINE. GEOGRAPHY SERIES | |
Abdulrahman et al. | IN-VITROCONJUGATED-LINOLEIC-ACID-FORMATION-BY-NEWLY-ISOLATED-ANAEROBIC-GUT-FUNGI | |
Paliy et al. | Influence of various prebiotic components on the main growth indicators of probiotic bacteria | |
KR20240026429A (en) | Novel Schizochytrium sp. strain producing a biomass containing high protein content, antioxidant pigments and omega-3 fatty acid and uses thereof | |
Liu et al. | Proliferation of probiotics and antioxidant effects of functional oligosaccharides added in fermented dairy product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16760561 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16760561 Country of ref document: EP Kind code of ref document: A1 |